Bereavement Support Program for Caregivers
A Palliative Bereavement Support Program in a Community Hospital Setting
1 other identifier
interventional
50
1 country
1
Brief Summary
To provide a palliative bereavement support program for caregivers to decrease the risk for developing complicated and persistent grief.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2023
CompletedFirst Submitted
Initial submission to the registry
April 9, 2023
CompletedFirst Posted
Study publicly available on registry
April 24, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2025
CompletedApril 24, 2023
April 1, 2023
2 years
April 9, 2023
April 21, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Change in Bereavement Experience Questionnaire (BEQ-24) from Baseline
Short form of 24 questions consisting of three subscales of 1) Existential Loss/Emotional Needs, 2) Guilt/Blame/Anger, and 3) Preoccupation with Thoughts of Deceased.
3 months
Change in Bereavement Experience Questionnaire (BEQ-24) from Baseline
Short form of 24 questions consisting of three subscales of 1) Existential Loss/Emotional Needs, 2) Guilt/Blame/Anger, and 3) Preoccupation with Thoughts of Deceased.
6 months
Secondary Outcomes (2)
Change in Patient Health Questionnaire-9 from Baseline
3 months
Change in Patient Health Questionnaire-9 from Baseline
6 months
Study Arms (2)
Vocal Expression
ACTIVE COMPARATORSupportive care through vocal expression sessions where participants can talk for approximately 20-30 minutes about the person who died.
Cognitive Behavioral
EXPERIMENTALCognitive-behavioral techniques with sessions consisting of approximately 20-30 minutes.
Interventions
There will be a total of 8 sessions. At baseline (week 0), only questionnaires will be completed. There will be 7 treatment sessions beginning at week 2, and the other sessions conducted at approximately every 3 weeks over the 6-month study duration where the vocal expression sessions will be provided.
There will be 8 treatment sessions where part of the baseline session of session 1 (week 0) will include some instruction, session 2 will occur in week 2, and the other sessions conducted at approximately every 3 weeks over the 6-month study duration. Sessions will include various cognitive-behavioral techniques including completing a grief monitoring diary, imaginal revisiting, cognitive restructuring, describing positive memories of the deceased, and identifying future goals.
Eligibility Criteria
You may qualify if:
- Informal family (or friend) caregivers, who are 18 years and older, who are caring for patients 18 years and older.
- Patient location may include the emergency department, or inpatient settings when patients are referred to Palliative Care services for end-of-life care.
- Caregivers for patients who die at the hospital are included in this study.
- Only will include those who speak English.
You may not qualify if:
- Caregivers or patients under the age of 18.
- Pregnant caregivers.
- Court appointed guardians.
- Caregivers who have history of psychiatric illness, high depression scores on the PHQ-9 (\>20), suicidal ideation, or anxiety symptoms of panic attacks on initial screening will not be included and will be provided contact information to obtain treatment at Behavioral Health.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
South Brooklyn Health
Brooklyn, New York, 11235, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Marina Ivanyuk, MD
New York City Health and Hospitals Corporation
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Palliative Care
Study Record Dates
First Submitted
April 9, 2023
First Posted
April 24, 2023
Study Start
April 1, 2023
Primary Completion
April 1, 2025
Study Completion
April 1, 2025
Last Updated
April 24, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share
We do not plan to share individual participant data with other researchers.